Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 5739 (miR-5739) is a human microRNA (non-coding RNA) that plays an essential role in embryonic mesoderm development, specifically controlling the proliferation, differentiation, and maturation of muscle and vascular cell lineages through post-transcriptional gene silencing. It acts by binding the 3′ untranslated regions of target mRNAs to suppress their expression, directly regulating key genes such as SMA, Brachyury T, Hand1 (in muscle lineage), and KDR and Endoglin (in vascular lineage). Experimental knockout of miR-5739 in human embryonic stem cells leads to profound defects in muscle and blood vessel formation, while its expression is markedly decreased in pathological tissues from patients with both congenital muscle and vascular diseases. These functions highlight miR-5739 as a promising candidate for cell therapy research in genetic diseases and as a novel biomarker for diagnosis and monitoring of muscle/vascular pathologies.
Binds to target gene 3′ untranslated regions to suppress expression via RNA interference (canonical miRNA action). Targets specific genes for muscle (SMA, Brachyury T, Hand1) and vascular (KDR, Endoglin) differentiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 5739 (miR-5739).